The FDA said that over 140,000 bottles of the Lipitor generic potentially failed to meet "dissolution specifications." ...

This 24-week, randomized, open-label trial (Trial Number: 4522IL/0029) was conducted at 39 participating centers in the United States. [21] Eligible patients were randomized at a 2:3:3:3 ratio to ...

Sun Pharmaceutical Industries has announced the launch of FEXUCLUE, a novel potassium-competitive acid blocker (P-CAB), in India. The drug, available in 40 mg tablets, is approved as a new treatment ...

Sun Pharmaceutical Industries Limited has announced the launch of FEXUCLUE® (Fexuprazan) 40 mg tablets in India, a novel treatment for Erosive Esophagitis. FEXUCLUE® is a Potassium-Competitive Acid ...

Renata PLC is excited to announce the successful shipment of its first consignment of Rosuvastatin to the U.S. market. Manufactured at Renata's US FDA-approved facility in Bangladesh, Renata's product ...

Department of Clinical Research, Industrias Biocontrolled C.A., Caracas, Venezuela. The 2019 ESC/EAS Guidelines for managing hyperlipidemia recommend combining lifestyle changes and medications based ...

Department of Clinical Research, Industrias Biocontrolled C.A., Caracas, Venezuela. This study was conducted ethically in accordance with the principles of the Declaration of Helsinki (Brazil, 2.013) ...

Background In Europe, the urate-lowering drug febuxostat for gout is registered in two strenghts, 80 mg and 120 mg, but not 40 mg. Starting 40 mg can sometimes be considered desirable, for instance ...

Genetic differences could account for variations in statin pharmacokinetics between Asians and Westerners. 9 Accordingly, because of a higher drug exposure, Asians might achieve similar benefits from ...